A preliminary study of growth hormone in the treatment of dilated cardiomyopathy

New England Journal of Medicine

Volumn 334, Issue 13, 1996, Pages 809-814

  Fazio, Serafino ^a   Sabatini, Domenico ^a   Capaldo, Brunella ^a   Vicorito, Carlo ^a   Giordano, Arturo ^a   Guida, Raffaele ^a   Pardo, Francesco ^a   Biondi, Bernadette ^a   Saccà, Luigi ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; DRUG EFFECT; DRUG EFFICACY; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HEART DILATATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE METABOLISM; HEART VENTRICLE FUNCTION; HORMONAL THERAPY; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GROWTH HORMONE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; RECOMBINANT PROTEINS;

EID: 0030010229     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199603283341301     Document Type: Article

References (39)

1. Kasper EK, Agema WRP, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994;23:586-90.
2. Dec GW, Faster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331:1564-75.
3. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976;18:225-64.
4. Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994;15:555-73.
5. Saccà L, Fazio S. Cardiac performance: growth hormone enters the race. Nat Med 1996;2:29-31.
6. Merola B, Cittadini A, Colao A, et al. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 1993;77:1658-61.
7. Amato G, Carella C, Fazio S, et al. Body composition, bone metabolism, heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses J Clin Endocrinol Metab 1993;77:1671-6.
8. Cittadini A, Cuocolo A, Merola B, et al. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol 1994;267:E219-E225.
9. Thuesen L, Christensen SE, Weeke J, Ørskov H, Henningsen P. A hyperkinetic heart in uncomplicated active acromegaly. explanation of hypertension in acromegalic patients? Acta Med Scand 1988;223.337-43.
10. Chanson PJ, Timsit J, Masquet C, et al. Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med 1990;113.921-5.
11. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien K. Ross J Jr. Insulinlike growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619-27.
12. Yang R, Bunting S, Gillett N, Clark R, Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 1995;92: 262-7.
13. Rubin SA, Buttrick P, Malhotra A, Melmed S, Fishbem MC Cardiac physiology, biochemistry and morphology in response to excess growth hormone in the rat. J Mol Cell Cardiol 1990;22:429-38.
14. Timsit J, Riou B, Bertherat J, et al. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle J Clin Invest 1990;86:507-15.
15. Mayoux E, Ventura-Clapier R, Timsit J, Béhar-Cohen F, Hoffmann C, Mercadier J-J. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circ Res 1993,72:57-64.
16. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation 1993;87:Suppl VII:VII-58-VII-62.
17. Zhang J, McDonald KM. Bioenergetic consequences of left ventricular remodeling Circulation 1995;92.1011-9.
18. Baxley WA, Dodge HT, Rackley CE, Sandler H, Pugh D. Left ventricular mechanical efficiency in man with heart disease. Circulation 1977,55:564-8.
19. Hasenfuss G, Holubarsch C, Heiss HW, et al Myocardial energetics in patients with dilated cardiomyopathy: influence of nitroprusside and enoximone Circulation 1989;80:51-64.
20. Nichols AB, Pearson MH, Sciacca RR, Cannon PJ. Left ventricular mechanical efficiency in coronary artery disease, J Am Coll Cardiol 1986;7:270-9
21. Møller J, Jørgensen JOL, Møller N, Hansen KW, Pedersen EB, Christiansen JS. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab 1991;72:768-72.
22. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
23. Fazio S, Cittadini A, Sabatini D, et al Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J 1993; 14:26-33.
24. Reichek N, Wilson J, Sutton MSJ, Plappert TA, Goldberg S, Hirshfeld JW. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 1982;65:99-108.
25. Tandon PK, Stander H, Schwarz RP Jr. Analysis of quality of life data from a randomized, placebo-controlled heart-failure trial. J Clin Epidemiol 1989; 42:955-62.
26. Pepine CJ, Mehta J, Webster WW Jr, Nichols WW. In vivo validation of a thermodilution method to determine regional left ventricular blood flow in patients with coronary disease. Circulation 1978;58:795-802.
27. Simonson DC, DeFronzo RA. Indirect calorimetry methodological and in terpretative problems. Am J Physiol 1990;258:E399-E412.
28. Armitage P, Berry G Statistical methods in medical research. 2nd ed. Oxford, England: Blackwell Scientific, 1987.
29. Frustaci A, Perrone GA, Gentiloni N, Russo MA. Reversible dilated cardiomyopathy due to growth hormone deficiency Am J Clin Pathol 1992,97 503-11.
30. Neubauer S, Horn M, Naumann A, et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest 1995;95:1092-100.
31. Hardy CW, Weiss RG, Bottomley PA, Gerstenbhth G. Altered myocardial high-energy phosphate metabolites in patients, with dilated cardiomyopathy. Am Heart J 1991;122:795-801.
32. Hamman BL, Bittl JA, Jacobus WE. et al. Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. Am J Physiol 1995;269:H1030-H1036.
33. Lombarde TA, Rose L, Taeschler M, Tuluy S, Bing RJ. The effect of exercise on coronary blood flow, myocardial oxygen consumption and cardiac efficiency in man Circulation 1953;7:71-8.
34. Gorlin R, Cohen LS, Elliott WC, Klein MD, Lane FJ Effect of supine exercise on left ventricular volume and oxygen consumption in man. Circulation 1965;32:361-71.
35. Nozawa T, Cheng C-P, Noda T, Little WC Effect of exercise on left ventricular mechanical efficiency in conscious dogs. Circulation 1994;90:3047-54.
36. Suga H. Ventricular energetics. Physiol Rev 1990;70:247-77.
37. Strauer BE. Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve Am J Cardiol 1979;44. 730-40.
38. De Marco T, Chatterjee K, Rouleau J-L, Parmley WW. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J 1988;115:809-15.
39. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6.